AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 101 min read$TWST

Green Paula sold $111K of TWST

Green Paula (SVP of Human Resources) sold 907 shares of Twist Bioscience Corp (TWST) at $122.62 ($0.11M total) on 2026-09-08.

Original reporting
SEC EDGAR · Green Paula
Published Sep 10, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TWST
Neutral
high confidence
Mentioned
$TWST
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWSTNeutralLow
01

Why it matters

The disclosed sale is modest and does not suggest a shift in company fundamentals.

02

Market read

Routine insider sell with limited trading relevance.

03

What to watch

Potential upcoming dilution or financing events not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-10

Background

Form 4 filings disclose insider transactions; traders monitor them for signals of confidence.

Company-level read

Ticker impact

$TWSTNeutralHigh confidence
Context

SVP of HR Green Paula sold 907 shares for $111K, reducing her stake to 117,014 shares.

Expected impact

No significant impact; price may stay flat or dip slightly on volume.

Evidence & confidence

The sale size is small relative to market cap and insider ownership; no change in control or strategic direction.

Market effects

Sector

None; HR insider activity does not affect biotech sector trends.

Regional

None; the filing is U.S.-based and limited to Twist Bioscience.

Global

Minimal; only relevant to investors tracking insider activity.

Counterpoint

What could challenge this read

If the insider is privy to upcoming negative news, the sale could foreshadow a downside.

Key entities

  • Company
    Twist Bioscience Corp

    Biotech company listed on NASDAQ.

  • Insider
    Green Paula

    Senior Vice President of Human Resources.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TWST insider trading history →

Related articles

OCT 5
$TWSTHigh

Twist Bioscience TWST Stock Jumps On AI Drug Discovery Deals

Twist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.

timothysykes.com3 min
SEP 24
$TWSTMed

Twist Bioscience Stock Jumps As Lilly AI Deal Fuels Bullish Target Hike

Twist Bioscience (TWST) stock rose 16.21% after announcing a partnership with Eli Lilly's AI drug discovery platform, TuneLab. The company reported Q3 revenue of $118.4M, with a gross margin of 52% but a net loss of $35.1M. Leerink raised its price target to $160, citing the AI-driven opportunity. TWST is trading at a high valuation with a price-to-sales ratio over 25.

timothysykes.com3 min
SEP 24
$TWSTMed

Twist Bioscience Stock Jumps As AI Deals Fuel Bullish Target Hike

Twist Bioscience (TWST) stock rose 8.35% on September 24, 2026, driven by its AI partnership with Eli Lilly's TuneLab platform. The company's stock has seen significant gains recently, trading at $171.74 from $139 over a few weeks. TWST reported quarterly revenue of $118.38M, with a net loss of $35.05M. Leerink raised its price target to $160, citing AI drug discovery opportunities.

timothysykes.com3 min